SciSight Ecosystem
WoS ESCI Q4Scopus Q3SCImago #19,241CAS 4区Review JournalHybrid

Expert Review of Precision Medicine and Drug Development

Country: United Kingdom•WoS SCIE Quartile: Q4•Scopus SJR: 0.25•SCImago Rank: #19,241•Identifier (ISSN):2380-8993(Print)•Articles / Year: 28•Estimated Publication Fee (APC): $2,622 USD
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q4
1.5
↑ +0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
19

19 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
28articles/year
20% Gold OA•50% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 1.5)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 1.5)
🔵 Computed
20251.00đ
WoS Q4(IF: 1.2)
🔵 Computed
20241.00đ
WoS Q4(IF: 1)
🔵 Computed
20231.00đ
WoS Q4(IF: 1.2)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Expert Review of Precision Medicine and Drug Development publishes primarily review articles covering the development and clinical application of medicine to be used in a personalized therapy setting; in addition, the journal also publishes original research and commentary-style articles. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it has become necessary to identify patients responsive to treatments and treat patient populations using a tailored approach. Areas covered include: Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this. Clinical trials and case studies within personalized therapy and drug development. Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment. Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies. Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.

Topics Covered (Recognized by AI)
Medicine98.1%Biology92.5%Genetics82%Internal medicine75.2%Pathology59.8%Chemistry42.5%Biochemistry39.8%Precision medicine36.8%Computer science34.2%Cancer33.1%Bioinformatics32.7%Gene29.7%Oncology28.9%Immunology26.7%Psychology25.6%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #19,241Scopus Q3SCImago Profile
Scopus Coverage:2016-2025
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.25

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
19

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.89

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,622 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations34
3-Year Documents27
Citable Documents20

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate38.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ3
Drug DiscoveryQ4
GeneticsQ4
Molecular MedicineQ4

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Taylor & Francis
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PHARMACOLOGY & PHARMACY
JCRESCI
286/356Q4
PHARMACOLOGY & PHARMACY
JCIESCI
336/356Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

10 year
YearImpact FactorArticles / YearTotal Citations
20251.2421
20241611
20231.2335
2022—1231
2021—36184
2020—53320
2019—34584
2018—40432
2017—42644
2016—52845
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Expert Review of Precision Medicine and Drug Development

WoS Q4
01122023202420251.20
Annual Impact Factor Metric
2025:1.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 1d8a6ae1-f0c7-4941-81ac-29ce1074d3bb
Database Updated: 2026-10-01